Effect of Combining Ivabradine and ?-Blockers: Focus on the Use of Carvedilol in the SHIFT Population
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33157491" target="_blank" >RIV/61989592:15110/15:33157491 - isvavai.cz</a>
Result on the web
<a href="http://Effect" target="_blank" >http://Effect</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000380812" target="_blank" >10.1159/000380812</a>
Alternative languages
Result language
angličtina
Original language name
Effect of Combining Ivabradine and ?-Blockers: Focus on the Use of Carvedilol in the SHIFT Population
Original language description
OBJECTIVES: We explored the prescription of ?-blockers with ivabradine in patients with systolic heart failure, focusing on the most frequently coprescribed ?-blocker, carvedilol. METHODS: We analyzed outcomes in SHIFT patients with systolic heart failure who were prescribed ?-blockers (carvedilol, bisoprolol, metoprolol, or nebivolol) with ivabradine or placebo. Analysis was by intention to treat in patients prescribed a ?-blocker at the time of the event. RESULTS: Data were available for 2,596 patients receiving carvedilol, 1,483 bisoprolol, 1,424 metoprolol, and 197 nebivolol. Mean treatment duration was 19 months. There was no difference in the effect of ivabradine on the primary composite endpoint of cardiovascular death or heart failure hospitalization between the various ?-blockers [hazard ratios (HR) for risk reduction, 0.75-0.89; p for interaction=0.86]. Patients prescribed carvedilol with ivabradine had lower rates of primary composite endpoint (HR 0.80, 95% CI: 0.68-0.94), h
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cardiology
ISSN
0008-6312
e-ISSN
—
Volume of the periodical
131
Issue of the periodical within the volume
4
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
218-224
UT code for WoS article
—
EID of the result in the Scopus database
—